Paliperidone Tablet, Extended Release
Product Images NDC 69367-432

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Paliperidone (NDC 69367-432). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Westminster Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Paliperidone 01)

Chemical structure of paliperidone, an active pharmaceutical ingredient used in extended-release oral tablets. The diagram shows the molecular arrangement including rings, bonds, and functional groups characteristic of paliperidone.*

FDA Label Image

Principal Display Panel (1.5 mg Tablet Bottle Label)

Label for Paliperidone Extended-Release Tablets 1.5 mg by Westminster Pharmaceuticals, LLC. It indicates a 30-tablet supply with instructions to swallow tablets whole without dividing, crushing, or chewing. The label includes NDC 69367-432-30, storage instructions, and manufacturer details.*

FDA Label Image

Principal Display Panel (3 mg Tablet Bottle Label)

Paliperidone Extended-Release Tablets label for the 3 mg strength. The label indicates 30 tablets per package, manufactured by Westminster Pharmaceuticals, LLC. It includes usage directions stating tablets should be swallowed whole and taken once daily. The label also shows the NDC 69367-433-30, barcode, and storage instructions.*

FDA Label Image

Principal Display Panel (6 mg Tablet Bottle Label)

Paliperidone Extended-Release Tablets 6 mg oral tablets packaging label showing 30 tablets per container. The label includes prescribing warnings, dosage instructions, storage conditions, and identifies Westminster Pharmaceuticals, LLC as the labeler and manufacturer information for licensing. The NDC 69367-434-30 and a barcode are present.*

FDA Label Image

Principal Display Panel (9 mg Tablet Bottle Label)

Paliperidone 9 mg extended-release tablets label for oral use by Westminster Pharmaceuticals, LLC. The label shows NDC 69367-435-30 and indicates the product contains 30 tablets. Instructions specify the tablets should be swallowed whole and taken once daily, with warnings against dividing, crushing, or chewing the tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.